Private Placements of Common Stock and Warrant exercises - Tender Offer and Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions |
12 Months Ended | ||
|---|---|---|---|
Jul. 19, 2024 |
May 31, 2025 |
May 31, 2024 |
|
| Share-based Compensation | |||
| Common stock warrants to purchase shares | 127.1 | ||
| Exercise price of share | $ 0.09387 | ||
| Gross proceeds from warrant exercises | $ 11,900 | ||
| Net proceeds from warrant exercises | $ 10,400 | ||
| Shares issued during the period new issues shares | 25.4 | ||
| Placement agent fees and expenses | $ 1,400 | ||
| Percentage of gross proceeds | 13.00% | ||
| Legal fees | $ 100 | ||
| Fair value of exercised warrants | 1,700 | $ 236 | |
| Fair value due to repricing | $ 400 | ||
| Exercise of warrants for cash, shares | 10.4 | ||
| Exercise of warrants for cash | $ 1,100 | ||
| Cashless exercise of warrants, shares | 1.9 | ||
| Cashless exercise of warrants, warrants | 2.6 | ||
| Cashless exercise of warrants, exercise price | $ 0.09387 | ||
| Maximum | |||
| Share-based Compensation | |||
| Exercise price of share | 0.21 | ||
| Minimum | |||
| Share-based Compensation | |||
| Exercise price of share | $ 0.1 | ||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding when exercised on a cashless basis. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to repricing adjustment to fair value of warrant liability. No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders gross proceeds from exercising their stock warrants. No definition available.
|
| X | ||||||||||
- Definition Represents information relating to percentage of gross proceeds No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants, net of offering costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares of stock issued during the period in the non cash exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition The number of shares of stock issued during the period for warrants exercised for cash. No definition available.
|
| X | ||||||||||
- Definition The value of stock issued during the period for warrants exercised for cash. No definition available.
|
| X | ||||||||||
- Definition The number of warrants exercised in the noncash transactions. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|